NCT05827523View on ClinicalTrials.gov

Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

520

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions
Ovarian Cancer
Interventions
DRUG

Cisplatin

Hyperthermic intraperitoneal chemotherapy (HIPEC) with cisplatin 75mg/m2 after interval cytoreductive surgery

Trial Locations (1)

Unknown

RECRUITING

National Cancer Center, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV